लोड हो रहा है...

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma

Blockade of cytotoxic T-lymphocyte antigen-4 (CTLA-4) by ipilimumab leads to immune-mediated tumor regression and immune-related adverse events (irAEs), including diarrhea and colitis. The current analyses were undertaken to promote an understanding of the underlying mechanism of action and to ident...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Berman, David, Parker, Susan M., Siegel, Jonathan, Chasalow, Scott D., Weber, Jeffrey, Galbraith, Susan, Targan, Stephan R., Wang, Hanlin L.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Academy of Cancer Immunology 2010
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2999944/
https://ncbi.nlm.nih.gov/pubmed/21090563
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!